Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells
Authors:
Open Access
- 4 February 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 156 (2) , 303-311
Abstract
Summary: Inherited deficiencies in components of the classical complement pathway are strong disease susceptibility factors for the development of systemic lupus erythematosus (SLE) and there is a hierarchy among deficiency states, the strongest association being with C1q deficiency. We investigated the relative importance of the different complement pathways regarding clearance of apoptotic cells. Phagocytosis of labelled apoptotic Jurkat cells by monocyte-derived macrophages in the presence of sera from individuals with complement deficiencies was studied, as well as C3 deposition on apoptotic cells using flow cytometry. Sera from individuals deficient in C1q, C4, C2 or C3 all showed decreased phagocytosis. Mannose binding lectin (MBL) and the alternative pathway did not influence phagocytosis. Notably, the components of the complement classical pathway, including C1q, were equally important in clearance of apoptotic cells. This indicates that deposition of C3 fragments is of major significance; we therefore studied C3 deposition on apoptotic cells. Experiments with MBL-deficient serum depleted of C1q or factor D confirmed the predominance of the classical pathway. At low dilution, sera deficient of C1q, C4 or C2 supported C3 fragment deposition demonstrating alternative pathway activation. In conclusion, we have found that complement-mediated opsonization and phagocytosis of apoptotic cells, particularly those undergoing secondary necrosis, are dependent mainly upon an intact classical pathway. The alternative pathway is less important, but may play a role in some conditions. C1q was not more important than other classical pathway components, suggesting a role in additional pathogenetic processes in SLE other than clearance of apoptotic cells.Keywords
This publication has 38 references indexed in Scilit:
- The lectin‐like activity of human C1q and its implication in DNA and apoptotic cell recognitionFEBS Letters, 2008
- The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosisProceedings of the National Academy of Sciences, 2008
- Role of complement and complement regulators in the removal of apoptotic cellsMolecular Immunology, 2008
- The Classical and Regulatory Functions of C1q in Immunity and AutoimmunityCellular & Molecular Immunology, 2008
- Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2Journal of Clinical Investigation, 2006
- I-PLA2 Activation during Apoptosis Promotes the Exposure of Membrane Lysophosphatidylcholine Leading to Binding by Natural Immunoglobulin M Antibodies and Complement ActivationJournal of Experimental Medicine, 2002
- Direct binding of C1q to apoptotic cells and cell blebs induces complement activationEuropean Journal of Immunology, 2002
- Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.Journal of Clinical Investigation, 1998
- Activation of the alternative pathway of complement by apoptotic Jurkat cellsFEBS Letters, 1994
- Immune response to tetravalent meningococcal vaccine: Opsonic and bactericidal functions of normal and properdin deficient seraEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989